 | Up a level |
Journal Article
Franklin, Cindy 
ORCID: 0000-0001-9142-5423, Mohr, Peter, Bluhm, Leonie, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund ORCID: 0000-0003-4340-9706, Garzarolli, Marlene, Weichenthal, Michael ORCID: 0000-0002-9060-4961, Pfoehler, Claudia, Herbst, Rudolf ORCID: 0000-0002-4238-9486, Terheyden, Patrick, Utikal, Jochen, Ulrich, Jens, Debus, Dirk, Haferkamp, Sebastian, Kaatz, Martin, Forschner, Andrea, Leiter, Ulrike, Nashan, Dorothee, Kreuter, Alexander, Sachse, Michael, Welzel, Julia, Heinzerling, Lucie, Meiss, Frank, Weishaupt, Carsten, Gambichler, Thilo, Weyandt, Gerhard, Dippel, Edgar, Schatton, Kerstin, Celik, Eren, Trommer, Maike, Helfrich, Iris, Roesch, Alexander, Zimmer, Lisa ORCID: 0000-0002-3680-3521, Livingstone, Elisabeth, Schadendorf, Dirk, Horn, Susanne and Ugurel, Selma
(2022).
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
J. Immunother. Cancer, 10 (6).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2051-1426
Knispel, Sarah, Gassenmaier, Maximilian, Menzies, Alexander M., Loquai, Carmen, Johnson, Douglas B., Franklin, Cindy ORCID: 0000-0001-9142-5423, Gutzmer, Ralf, Hassel, Jessica C., Weishaupt, Carsten, Eigentler, Thomas, Schilling, Bastian, Schummer, Patrick, Sirokay, Judith ORCID: 0000-0003-3945-845X, Kiecker, Felix, Owen, Carina N., Fleischer, Maria, I, Cann, Christopher, Kaehler, Katharina C., Mohr, Peter, Bluhm, Leonie, Niebel, Dennis ORCID: 0000-0003-2069-0486, Thoms, Kai-Martin, Goldinger, Simone M., Reinhardt, Lydia, Meier, Friedegund, Berking, Carola, Reinhard, Raphael, Susok, Laura, Ascierto, Paolo A., Drexler, Konstantin, Pfoehler, Claudia, Tietze, Julia, Heinzerling, Lucie, Livingstone, Elisabeth, Ugurel, Selma, Long, Georgina, V, Stang, Andreas, Schadendorf, Dirk and Zimmer, Lisa ORCID: 0000-0002-3680-3521
(2021).
Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition.
Eur. J. Cancer, 148.
S. 61 - 76.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852